Asset Dedication LLC’s NeoGenomics NEO Stock Holding History

Asset Dedication LLC’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-134	Closed	-$1.58K	–	1161
2025 Q4	$1.58K	Hold	134	–	–	﹤0.01%	1022
2025 Q3	$1.03K	Hold	134	–	–	﹤0.01%	1065
2025 Q2	$980	Hold	134	–	–	﹤0.01%	1089
2025 Q1	$1.27K	Sell	134 -14	-9%	-$175	﹤0.01%	1000
2024 Q4	$2.44K	Hold	148	–	–	﹤0.01%	951
2024 Q3	$2.18K	Hold	148	–	–	﹤0.01%	1000
2024 Q2	$2.05K	Buy	+148	New	+$2.1K	﹤0.01%	1061
2020 Q2	–	Sell	-739	Closed	-$20K	–	675
2020 Q1	$20K	Buy	+739	New	+$22.1K	0.01%	395

Other funds holding NEO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Greenhouse Funds Baltimore, Maryland $1.96B AUM 36.47% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Asset Dedication LLC's NEO Position: Q1 2026 in Review

Asset Dedication LLC sold out of NeoGenomics (NEO) in Q1 2026, closing a stake of 134 shares — an estimated $1.58K sold.

Asset Dedication LLC first reported a position in NEO in Q1 2020 and held it in 8 quarters. The position peaked at $20K in Q1 2020. 253 funds tracked by Wall St. Rank hold NEO as of Q1 2026.

Asset Dedication LLC reported no remaining NeoGenomics position as of Q1 2026 after selling out during the quarter.
Asset Dedication LLC sold 134 NeoGenomics shares in Q1 2026, an estimated $1.58K.
Asset Dedication LLC first reported a position in NeoGenomics in Q1 2020 and held it in 8 quarters.
Asset Dedication LLC's NeoGenomics position peaked at $20K in Q1 2020.
253 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2026.

Based on Asset Dedication LLC's 13F filing for Q1 2026, filed 29 May 2026.